ADAM19 rs1422795: Understanding the Bipolar Disorder Link
The rs1422795 variant is a single nucleotide polymorphism located within the ADAM19 gene. It has been identified in research as a potential linkage signal for severe bipolar disorder specifically within certain Latin American pedigrees.
What each genotype means
Typical genetic profile
This genotype represents the common form of the ADAM19 variant. Research into this specific marker is limited, and it is not considered a diagnostic indicator for any condition.
This is the most common genotype observed across most global populations.
Variant carrier profile
You carry one copy of the variant allele associated with research into bipolar disorder in specific Latin American pedigrees. Because this association is based on limited evidence and specific ancestry, it does not predict your personal health outcomes.
The frequency of this heterozygous genotype varies significantly depending on individual ancestral background.
Variant homozygous profile
You carry two copies of the variant allele that has been identified as a potential linkage signal for bipolar disorder in certain Latin American studies. Current evidence is limited, and this finding should not be interpreted as a medical diagnosis or a definitive risk factor.
This genotype is less common and its prevalence is highly variable across different Latin American populations.
What is rs1422795?
The rs1422795 variant is a specific genetic change, or single nucleotide polymorphism (SNP), located on chromosome 5 at position 5q33.3. This location places it within the ADAM19 gene, which encodes a protein involved in complex biological processes. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. While most SNPs are common and have no observable effect on health, some are studied for their potential to influence susceptibility to complex conditions. The rs1422795 variant is categorized as a trait-associated marker, meaning it has been flagged in scientific studies for its statistical correlation with specific health outcomes rather than being a direct cause of a disease. Because it is located in a non-coding or regulatory region of the gene, researchers investigate whether it might influence how the ADAM19 protein is expressed or regulated in different tissues, particularly in the brain.
The Role of the ADAM19 Gene
The ADAM19 gene, also known as ADAM metallopeptidase domain 19, provides instructions for creating a protein that belongs to the ADAM family of enzymes. These proteins are membrane-anchored and are essential for cell-cell and cell-matrix interactions. They function like molecular scissors, cleaving other proteins on the cell surface to release signaling molecules or modify receptors. ADAM19 is known to play roles in neurogenesis, muscle development, and the regulation of various signaling pathways. Recent research has also linked mutations in ADAM19 to structural conditions like brachydactyly type E, where the protein's ability to cleave receptors like PTHR1 is impaired. Given its involvement in neurodevelopmental processes, scientists have hypothesized that variations in this gene could potentially influence brain function or psychiatric health, though the exact mechanisms connecting ADAM19 to mood regulation remain a subject of ongoing investigation.
Evidence and Associations
The association between rs1422795 and bipolar disorder is currently classified as having limited evidence. Most of the data linking this variant to psychiatric health comes from linkage studies focusing on specific Latin American pedigrees. In these studies, researchers look for patterns of inheritance within families to see if certain genetic markers are shared more frequently among affected individuals. While these findings provide a starting point for understanding the genetic architecture of bipolar disorder, they do not imply that the variant is a definitive cause of the condition. Bipolar disorder is a highly complex, polygenic condition, meaning it is influenced by the interaction of many different genes and environmental factors. Because the evidence is limited and specific to certain ancestral groups, it is not currently used as a diagnostic tool in clinical settings. Further large-scale genomic studies are required to validate these findings across more diverse populations.
Interpreting Your Genetic Information
It is important to understand that having a specific genotype for rs1422795 does not mean an individual will develop bipolar disorder. Genetic markers identified in research studies are statistical associations, not medical diagnoses. Many people carry variants associated with increased risk without ever developing the associated condition, and conversely, many people with the condition do not carry the variant. If you have concerns about your mental health or family history, the most appropriate step is to consult with a qualified healthcare professional or a genetic counselor. They can provide context based on your personal health history and clinical symptoms. Never use genetic information to make decisions about medication or treatment plans without discussing them with your clinician or pharmacist. Genetic data is only one piece of a much larger puzzle that includes clinical evaluation, environmental factors, and personal history.
How common is this variant?
The frequency of the rs1422795 variant is known to be highly variable across different global populations, with specific notes indicating it is particularly relevant in certain Latin American cohorts.
Frequently asked questions
Does having the rs1422795 variant mean I have bipolar disorder?
No. This variant is a statistical marker identified in research studies and is not a diagnostic test for bipolar disorder. Bipolar disorder is a complex condition influenced by many genetic and environmental factors.
Is ADAM19 a known cause of bipolar disorder?
Current research does not classify ADAM19 as a direct cause of bipolar disorder. While some studies have identified linkage signals in this gene, the evidence is limited and requires further validation.
Should I get tested for this variant?
Genetic testing for this specific variant is not currently recommended for clinical diagnosis or risk assessment. If you have concerns about your mental health, please consult a healthcare provider for a professional evaluation.
Where can I find more information on bipolar disorder genetics?
You can explore resources like MedlinePlus Genetics or the National Institute of Mental Health (NIMH) for reliable, evidence-based information on the genetics and biology of bipolar disorder.
Sources & further reading
Educational information only, last refreshed 9/20/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1422795?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29